Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Global, regional, and national burden of myocarditis and cardiomyopathy, 1990-2017

Haijiang Dai, Dor Lotan, Arsalan Abu Much, Arwa Younis, Yao Lu, Nicola Luigi Bragazzi, Jianhong Wu
doi: https://doi.org/10.1101/2020.09.08.20191007
Haijiang Dai
1Centre for Disease Modelling, York University, Toronto, Ontario, Canada
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dor Lotan
2Leviev Heart Center, Sheba Medical Center, Tel Hashomer; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
3Medical Screening Institute, Sheba Medical Center, Tel Hashomer, Tel-Aviv, Israel
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arsalan Abu Much
2Leviev Heart Center, Sheba Medical Center, Tel Hashomer; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel
3Medical Screening Institute, Sheba Medical Center, Tel Hashomer, Tel-Aviv, Israel
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arwa Younis
4Clinical Cardiovascular Research Center, University of Rochester Medical Center, Rochester, New York
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yao Lu
5Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robertobragazzi{at}gmail.com luyao0719{at}hotmail.com
Nicola Luigi Bragazzi
1Centre for Disease Modelling, York University, Toronto, Ontario, Canada
6Department of Health Sciences (DISSAL), Postgraduate School of Public Health, University of Genoa, Genoa, Italy
MD, PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robertobragazzi{at}gmail.com luyao0719{at}hotmail.com
Jianhong Wu
1Centre for Disease Modelling, York University, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background To estimate the burden of myocarditis (MC) and cardiomyopathy for 195 countries and territories from 1990 to 2017.

Methods We collected detailed information on MC and cardiomyopathy between 1990 and 2017 from the Global Burden of Disease study (GBD) 2017. Cardiomyopathy was divided into two types in GBD 2017, including alcoholic cardiomyopathy (AC) and other cardiomyopathy (OC). All estimates were presented as counts, age-standardised rates per 100 000 people and percentage change, with 95% uncertainty intervals (UIs).

Results Worldwide, there were 1.80 million (95% UI 1.64 to 1.98) cases of MC, 1.62 million (95% UI 1.37 to 1.90) cases of AC and 4.21 million (95% UI 3.63 to 4.87) cases of OC, contributing to 46 486 (95% UI 39 709 to 51 824), 88 890 (95% UI 80 935 to 96 290) and 233 159 (95% UI 213 677 to 248 289) deaths in 2017, respectively. At the national level, the age-standardised prevalence rates varied by 10.4 times for MC, 252.6 times for AC and 38.1 times for OC; and the age-standardised death rates varied by 43.9 times for MC, 531.0 times for AC and 43.3 times for OC. Between 1990 and 2017, despite the decreases in age-standardised rates, the global numbers of prevalent cases and deaths have significantly increased for all the diseases. Females had greater decreases in age-standardised prevalence and death rates than males for all the diseases.

Conclusions MC, AC and OC remain important global public health problems, and there are significant geographic variations in the burden for all these diseases. More effective and geo-specific strategies are necessary to counteract and mitigate the future burden of these diseases.

What is already known?

  • ➢ Myocarditis (MC), alcoholic cardiomyopathy (AC) and other cardiomyopathy (OC) impose a substantial economic burden on healthcare systems. Studies that have systematically assessed the global, regional, and national burden of these diseases are still scarce.

What are the new findings?

  • ➢ Globally, there were an estimated 1.80 million (95% uncertainty interval (UI) 1.64 to 1.98) cases of MC, 1.62 million (95% UI 1.37 to 1.90) cases of AC and 4.21 million (95% UI 3.63 to 4.87) cases of OC in 2017.

  • ➢ The global numbers of deaths due to MC, AC, and OC in 2017 were 46 486 (95% UI 39 709 to 51 824), 88 890 (95% UI 80 935 to 96 290) and 233 159 (95% UI 213 677 to 248 289), respectively.

  • ➢ Across 21 world regions, the highest age-standardised prevalence rates of MC, AC and OC were seen in High-income Asia Pacific, Eastern Europe and Southern Sub-Saharan Africa, respectively. While the highest age-standardised death rates of MC, AC and OC were seen in Oceania, Eastern Europe and Central Europe, respectively.

  • ➢ Despite the decreases in age-standardised rates, the global numbers of prevalent cases and deaths of MC, AC and OC have significantly increased between 1990 and 2017.

What do the new findings imply?

  • ➢ Our findings suggested that total numbers of prevalent cases and deaths of MC, AC and OC are increasing worldwide. More effective and geo-specific strategies aimed at counteracting and mitigating the future burden of these diseases are warranted.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the Canada Research Chair Program (230720), and Hunan Youth Talent Project (2019RS2014)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Because GBD 2017 used de-identified, aggregated data, a waiver of informed consent was reviewed and approved by the University of Washington Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used in this research are publicly available

http://ghdx.healthdata.org/gbd-results-tool

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted September 09, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Global, regional, and national burden of myocarditis and cardiomyopathy, 1990-2017
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Global, regional, and national burden of myocarditis and cardiomyopathy, 1990-2017
Haijiang Dai, Dor Lotan, Arsalan Abu Much, Arwa Younis, Yao Lu, Nicola Luigi Bragazzi, Jianhong Wu
medRxiv 2020.09.08.20191007; doi: https://doi.org/10.1101/2020.09.08.20191007
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Global, regional, and national burden of myocarditis and cardiomyopathy, 1990-2017
Haijiang Dai, Dor Lotan, Arsalan Abu Much, Arwa Younis, Yao Lu, Nicola Luigi Bragazzi, Jianhong Wu
medRxiv 2020.09.08.20191007; doi: https://doi.org/10.1101/2020.09.08.20191007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)